A DOUBLE‐BLIND, PLACEBO‐CONTROLLED STUDY OF MONOCLONAL ANTI‐INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) ADMINISTRATION TO PREVENT ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION
暂无分享,去创建一个
R. Zietse | W. Weimar | T. Gelder | A. Mulder | L. Vaessen | C. Hesse | J. Yzermans | Yzermans Jn